RAFFA WEALTH MANAGEMENT, LLC’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-803
Closed -$16K 1092
2024
Q2
$16K Hold
803
﹤0.01% 368
2024
Q1
$16K Buy
+803
New +$15.5K ﹤0.01% 350
2017
Q1
Sell
-1
Closed -$37 415
2016
Q4
$37 Hold
1
﹤0.01% 881
2016
Q3
$35 Hold
1
﹤0.01% 867
2016
Q2
$33 Hold
1
﹤0.01% 862
2016
Q1
$29 Hold
1
﹤0.01% 849
2015
Q4
$33 Hold
1
﹤0.01% 849
2015
Q3
$28 Hold
1
﹤0.01% 841
2015
Q2
$41 Hold
1
﹤0.01% 825
2015
Q1
$49 Hold
1
﹤0.01% 809
2014
Q4
$45 Buy
+1
New +$39 ﹤0.01% 751

Other funds holding AVNS

RAFFA WEALTH MANAGEMENT, LLC's AVNS Position: Q3 2024 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 803 shares — an estimated $16K sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in AVNS in Q4 2014 and held it in 11 quarters. The position peaked at $16K in Q2 2024. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

  • RAFFA WEALTH MANAGEMENT, LLC reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
  • RAFFA WEALTH MANAGEMENT, LLC sold 803 Avanos Medical shares in Q3 2024, an estimated $16K.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Avanos Medical in Q4 2014 and held it in 11 quarters.
  • RAFFA WEALTH MANAGEMENT, LLC's Avanos Medical position peaked at $16K in Q2 2024.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q3 2024, filed 27 Jul 2026.